KCR, a full service CRO, has announced that it will be moving to a new office in Boston, Massachusetts. The move is another milestone in the company strategy to be closer to partners and clients at the heart of the East Coast biotech and pharma hub.
“We are very excited about the new location in Boston and the ability to serve our U.S. clients on the same ground,” said Mike Jagielski, CEO and president of KCR. “Boston is home to many life sciences companies, and we are proud to be part of this community.”
The Boston area is a top pharma and biopharma hub with Massachusetts ranked the most innovative U.S. state by Bloomberg (Dec, 2016). The new KCR office, located at Rowes Wharf downtown, translates into a perfect location to support innovative R&D projects.
“KCR continues its growth strategy by expanding its capacities to provide clients with customized, reliable and high-quality clinical research services,” added Jagielski. “With our new Boston location, our U.S. presence as well as our strong East—West footprint across 20 countries in Europe, we are uniquely positioned to engage in the most challenging clinical research studies. This is another extraordinary achievement, given our 20th anniversary being celebrated in 2017,” he summarized. Visit KCR to learn more.